Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis

Heather M. Berens, Kristen J. Polinski, Ted R. Mikuls, Sonia Khatter, Justin August, Ashley Visser, Michael Mahler, Michael H. Weisman, James R. O'Dell, Richard M. Keating, Jane H. Buckner, Peter K. Gregersen, Jill M. Norris, V. Michael Holers, Kevin D. Deane, M. Kristen Demoruelle

Research output: Contribution to journalArticle

Abstract

Objective. We investigated the association of age and anticyclic citrullinated peptide antibodies (anti-CCP) in subjects without rheumatoid arthritis (RA). Methods. Serum was tested for anti-CCP3.1 (IgG/IgA) in 678 first-degree relatives (FDR) of patients with RA and 330 patients with osteoarthritis (OA). Individual isotypes (anti-CCP-IgA and anti-CCP-IgG) were also tested in all FDR. Results. In FDR, increasing age was significantly associated with positivity for anti-CCP3.1 (per year, OR 1.03) and anti-CCP-IgA (per year, OR 1.05) but not anti-CCP-IgG. In FDR and OA subjects, anti-CCP3.1 prevalence was significantly increased after age 50 years. Conclusion. Increasing age in individuals without RA should be considered in the interpretation of anti-CCP3.1 positivity.

Original languageEnglish (US)
Pages (from-to)1556-1559
Number of pages4
JournalJournal of Rheumatology
Volume46
Issue number12
DOIs
StatePublished - Dec 1 2019

Fingerprint

Immunoglobulin A
Rheumatoid Arthritis
Peptides
Antibodies
Osteoarthritis
Immunoglobulin G
Serum

Keywords

  • AGE
  • ANTICYCLIC CITRULLINATED PEPTIDE ANTIBODIES
  • RHEUMATOID ARTHRITIS

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

Berens, H. M., Polinski, K. J., Mikuls, T. R., Khatter, S., August, J., Visser, A., ... Demoruelle, M. K. (2019). Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis. Journal of Rheumatology, 46(12), 1556-1559. https://doi.org/10.3899/jrheum.180897

Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis. / Berens, Heather M.; Polinski, Kristen J.; Mikuls, Ted R.; Khatter, Sonia; August, Justin; Visser, Ashley; Mahler, Michael; Weisman, Michael H.; O'Dell, James R.; Keating, Richard M.; Buckner, Jane H.; Gregersen, Peter K.; Norris, Jill M.; Holers, V. Michael; Deane, Kevin D.; Demoruelle, M. Kristen.

In: Journal of Rheumatology, Vol. 46, No. 12, 01.12.2019, p. 1556-1559.

Research output: Contribution to journalArticle

Berens, HM, Polinski, KJ, Mikuls, TR, Khatter, S, August, J, Visser, A, Mahler, M, Weisman, MH, O'Dell, JR, Keating, RM, Buckner, JH, Gregersen, PK, Norris, JM, Holers, VM, Deane, KD & Demoruelle, MK 2019, 'Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis', Journal of Rheumatology, vol. 46, no. 12, pp. 1556-1559. https://doi.org/10.3899/jrheum.180897
Berens, Heather M. ; Polinski, Kristen J. ; Mikuls, Ted R. ; Khatter, Sonia ; August, Justin ; Visser, Ashley ; Mahler, Michael ; Weisman, Michael H. ; O'Dell, James R. ; Keating, Richard M. ; Buckner, Jane H. ; Gregersen, Peter K. ; Norris, Jill M. ; Holers, V. Michael ; Deane, Kevin D. ; Demoruelle, M. Kristen. / Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis. In: Journal of Rheumatology. 2019 ; Vol. 46, No. 12. pp. 1556-1559.
@article{cb6c073a50cf4eda87b3155b379fa2d1,
title = "Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis",
abstract = "Objective. We investigated the association of age and anticyclic citrullinated peptide antibodies (anti-CCP) in subjects without rheumatoid arthritis (RA). Methods. Serum was tested for anti-CCP3.1 (IgG/IgA) in 678 first-degree relatives (FDR) of patients with RA and 330 patients with osteoarthritis (OA). Individual isotypes (anti-CCP-IgA and anti-CCP-IgG) were also tested in all FDR. Results. In FDR, increasing age was significantly associated with positivity for anti-CCP3.1 (per year, OR 1.03) and anti-CCP-IgA (per year, OR 1.05) but not anti-CCP-IgG. In FDR and OA subjects, anti-CCP3.1 prevalence was significantly increased after age 50 years. Conclusion. Increasing age in individuals without RA should be considered in the interpretation of anti-CCP3.1 positivity.",
keywords = "AGE, ANTICYCLIC CITRULLINATED PEPTIDE ANTIBODIES, RHEUMATOID ARTHRITIS",
author = "Berens, {Heather M.} and Polinski, {Kristen J.} and Mikuls, {Ted R.} and Sonia Khatter and Justin August and Ashley Visser and Michael Mahler and Weisman, {Michael H.} and O'Dell, {James R.} and Keating, {Richard M.} and Buckner, {Jane H.} and Gregersen, {Peter K.} and Norris, {Jill M.} and Holers, {V. Michael} and Deane, {Kevin D.} and Demoruelle, {M. Kristen}",
year = "2019",
month = "12",
day = "1",
doi = "10.3899/jrheum.180897",
language = "English (US)",
volume = "46",
pages = "1556--1559",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

TY - JOUR

T1 - Anticyclic citrullinated peptide antibodies 3.1 and anti-CCP-IgA are associated with increasing age in individuals without rheumatoid arthritis

AU - Berens, Heather M.

AU - Polinski, Kristen J.

AU - Mikuls, Ted R.

AU - Khatter, Sonia

AU - August, Justin

AU - Visser, Ashley

AU - Mahler, Michael

AU - Weisman, Michael H.

AU - O'Dell, James R.

AU - Keating, Richard M.

AU - Buckner, Jane H.

AU - Gregersen, Peter K.

AU - Norris, Jill M.

AU - Holers, V. Michael

AU - Deane, Kevin D.

AU - Demoruelle, M. Kristen

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Objective. We investigated the association of age and anticyclic citrullinated peptide antibodies (anti-CCP) in subjects without rheumatoid arthritis (RA). Methods. Serum was tested for anti-CCP3.1 (IgG/IgA) in 678 first-degree relatives (FDR) of patients with RA and 330 patients with osteoarthritis (OA). Individual isotypes (anti-CCP-IgA and anti-CCP-IgG) were also tested in all FDR. Results. In FDR, increasing age was significantly associated with positivity for anti-CCP3.1 (per year, OR 1.03) and anti-CCP-IgA (per year, OR 1.05) but not anti-CCP-IgG. In FDR and OA subjects, anti-CCP3.1 prevalence was significantly increased after age 50 years. Conclusion. Increasing age in individuals without RA should be considered in the interpretation of anti-CCP3.1 positivity.

AB - Objective. We investigated the association of age and anticyclic citrullinated peptide antibodies (anti-CCP) in subjects without rheumatoid arthritis (RA). Methods. Serum was tested for anti-CCP3.1 (IgG/IgA) in 678 first-degree relatives (FDR) of patients with RA and 330 patients with osteoarthritis (OA). Individual isotypes (anti-CCP-IgA and anti-CCP-IgG) were also tested in all FDR. Results. In FDR, increasing age was significantly associated with positivity for anti-CCP3.1 (per year, OR 1.03) and anti-CCP-IgA (per year, OR 1.05) but not anti-CCP-IgG. In FDR and OA subjects, anti-CCP3.1 prevalence was significantly increased after age 50 years. Conclusion. Increasing age in individuals without RA should be considered in the interpretation of anti-CCP3.1 positivity.

KW - AGE

KW - ANTICYCLIC CITRULLINATED PEPTIDE ANTIBODIES

KW - RHEUMATOID ARTHRITIS

UR - http://www.scopus.com/inward/record.url?scp=85075957626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075957626&partnerID=8YFLogxK

U2 - 10.3899/jrheum.180897

DO - 10.3899/jrheum.180897

M3 - Article

C2 - 30988128

AN - SCOPUS:85075957626

VL - 46

SP - 1556

EP - 1559

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -